Pharvaris stock surged Wednesday — and KalVista reversed higher — on promising test results for an HAE treatment. The post Pharvaris Surges, Pulling KalVista Out Of A Slump, On Promising New HAE Treatment appeared first on Investor's Business Daily.
Continue reading...
Continue reading...